Afya Releases Study on AI Adoption in Brazilian Healthcare
Afya published a research study in partnership with Conexa Research Center detailing the current adoption rates and usage patterns of artificial intelligence among Brazilian physicians.
Stocks · News reference
JP Morgan analyst Marcelo Santos upgrades Afya (NASDAQ:AFYA) from Neutral to Overweight and lowers the price target from $21 to $19.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Afya published a research study in partnership with Conexa Research Center detailing the current adoption rates and usage patterns of artificial intelligence among Brazilian physicians.
Analysts upgraded NetApp, Humana, Corteva, Afya, with price-target changes for four stocks.